Local News Seagen Announces Updated Results from Pivotal HER2CLIMB Trial Evaluating TUKYSA® (Tucatinib) in Patients with HER2-Positive Breast Cancer with Brain MetastasesSeagen | December 13, 2021Seagen Inc. announced the presentation of new data from exploratory analyses from the pivotal HER2CLIMB…dcorriganDecember 13, 2021 Read More
Local News The Most Influential Scientists, Doctors, and Environmentalists in SeattleSeattle Met | December 13, 2021Kemi Doll is used to being one of the only—or the only—Black women in a room,…dcorriganDecember 13, 2021 Read More
Local News Mapping Function: Translating Adaptive Immune System Insights into Diagnostics and DrugsGenetic Engineering & Biotechnology News | December 10, 2021Adaptive Biotechnologies is ‘scratching the surface’ in its quest to create a disease-by-disease map of…dcorriganDecember 10, 2021 Read More
Local News ISB Creates Algorithms to Accelerate Discovery of Efficacious Treatments for TuberculosisInstitute for Systems Biology | December 9, 2021Tuberculosis (TB) is the world’s second leading infectious disease killer after COVID-19. One-and-a-half million people…dcorriganDecember 9, 2021 Read More
Local News Seattle Children’s Researchers Discover That Nanobodies Could Pack the Biggest Punch against COVID-19 Variants and ResurgenceSeattle Children's | December 8, 2021When the worst pandemic of the century struck, a group of nine Seattle Children’s Research Institute’s…dcorriganDecember 8, 2021 Read More
Local News Cyrus Biotechnology Announces $18M Financing and Acquisition of Orthogonal Biologics to Form an Integrated Software-Driven Pre-Clinical-Stage Drug Discovery FirmCyrus Biotechnology | December 8, 2021Cyrus Biotechnology, Inc., a Seattle-based biotechnology firm with a proprietary software platform for biologics discovery,…dcorriganDecember 8, 2021 Read More
Local News Science Says: Fearless ScienceFred Hutch | December 7, 2021Timid research doesn't save lives. On Nov. 30, Fred Hutchinson Cancer Research Center brought several…dcorriganDecember 7, 2021 Read More
Local News Inherited Mutation Linked to Aggressive Prostate CancerUW Medicine | December 7, 2021Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate…dcorriganDecember 7, 2021 Read More
Local News Tune Therapeutics Launches with $40M in Funding, Aims to Fine-Tune Activity of Genes in CellsGeekWire | December 7, 2021A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40…dcorriganDecember 7, 2021 Read More
Local News Dr. Christopher Li named associate director of Diversity, Equity and Inclusion for Fred Hutch/UW Cancer ConsortiumFred Hutch | December 6, 2021The Fred Hutch/University of Washington Cancer Consortium has named Dr. Christopher Li its first associate director of…dcorriganDecember 6, 2021 Read More